

Learn about Afrezza side effects, from common cough and sore throat to serious warnings. Know what to expect and when to call your doctor.
Afrezza is an inhaled insulin used to control blood sugar in adults with type 1 or type 2 diabetes. Because you breathe it into your lungs rather than inject it, Afrezza has a unique side effect profile compared to other insulins. Knowing what to expect can help you feel more prepared and know when something needs medical attention.
If you are new to Afrezza, you may also want to read What Is Afrezza? Uses, Dosage, and What You Need to Know for a broader overview.
The following side effects are reported frequently in clinical trials. Most are mild and tend to improve as your body gets used to the medication:
The cough is the side effect that surprises most new Afrezza users. Here is what helps:
Low blood sugar is a risk with any insulin. To reduce your risk:
While rare, some side effects require immediate medical attention:
Afrezza carries a boxed warning about the risk of acute bronchospasm — a sudden tightening of the muscles around your airways. This is most dangerous for people with asthma or COPD, which is why Afrezza is contraindicated in those patients. If you experience sudden wheezing, difficulty breathing, or chest tightness after inhaling Afrezza, seek emergency medical care immediately.
Severe low blood sugar can cause confusion, seizures, or loss of consciousness. If you or someone you are with cannot treat the low blood sugar by eating or drinking, call 911. Make sure people around you know how to use glucagon if you have been prescribed it.
Insulin can shift potassium into cells, lowering blood potassium levels. Symptoms include muscle weakness, cramps, and irregular heartbeat. This is more common at higher doses or when combined with other medications that lower potassium.
Severe allergic reactions (anaphylaxis) are rare but possible. Signs include rash, swelling of the face or throat, difficulty breathing, and rapid heartbeat. Seek emergency help if you suspect an allergic reaction.
Afrezza may cause a gradual decline in pulmonary function over time. This is why your doctor will order regular spirometry tests. A small decrease in FEV1 has been observed in clinical trials. If you notice increasing shortness of breath over time, report it to your doctor.
During clinical trials, a small number of lung cancer cases were reported among Afrezza users. While no direct causal link has been established, the FDA recommends monitoring. If you have a history of lung cancer, discuss the risks with your doctor before starting Afrezza.
Afrezza is not safe for everyone. It is contraindicated in:
For more on who should avoid Afrezza, see our article on Afrezza drug interactions.
If you are considering switching from injectable insulin (like Humalog, NovoLog, or Fiasp) to Afrezza, here is how the side effects compare:
Learn more about how Afrezza compares to alternatives in our guide: Alternatives to Afrezza.
Contact your healthcare provider if you experience:
Call 911 or go to the emergency room for:
Keeping a simple log of any side effects you notice — when they happen, how severe they are, and how long they last — can help your doctor make better decisions about your treatment. Many diabetes apps let you track symptoms alongside your blood sugar readings.
If you are having trouble finding Afrezza at your pharmacy, check our guide on how to check if a pharmacy has Afrezza in stock or use MedFinder to search availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.